Strs Ohio boosted its position in shares of Molina Healthcare Inc. (NYSE:MOH) by 19.6% during the second quarter, Holdings Channel reports. The fund owned 25,000 shares of the company’s stock after buying an additional 4,100 shares during the period. Strs Ohio’s holdings in Molina Healthcare were worth $1,247,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the stock. Bank of Montreal Can purchased a new stake in Molina Healthcare during the second quarter worth approximately $13,970,000. Teachers Advisors Inc. boosted its stake in Molina Healthcare by 209.7% in the first quarter. Teachers Advisors Inc. now owns 245,142 shares of the company’s stock worth $15,809,000 after buying an additional 166,000 shares during the last quarter. Renaissance Technologies LLC boosted its stake in Molina Healthcare by 15.2% in the first quarter. Renaissance Technologies LLC now owns 1,208,150 shares of the company’s stock worth $77,914,000 after buying an additional 159,572 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in Molina Healthcare by 50.4% in the second quarter. BNP Paribas Arbitrage SA now owns 332,385 shares of the company’s stock worth $16,586,000 after buying an additional 111,396 shares during the last quarter. Finally, Rafferty Asset Management LLC purchased a new stake in Molina Healthcare during the first quarter worth approximately $2,311,000. 87.59% of the stock is owned by institutional investors.
Molina Healthcare Inc. (NYSE:MOH) traded down 0.96% during mid-day trading on Wednesday, hitting $56.98. 548,452 shares of the stock were exchanged. The firm has a market cap of $3.24 billion, a price-to-earnings ratio of 24.67 and a beta of 1.54. The company has a 50 day moving average price of $56.41 and a 200 day moving average price of $54.72. Molina Healthcare Inc. has a 52-week low of $44.50 and a 52-week high of $70.82.
Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 27th. The company reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.18. The firm earned $4.36 billion during the quarter, compared to analysts’ expectations of $4.35 billion. Molina Healthcare had a net margin of 0.83% and a return on equity of 9.60%. The business’s quarterly revenue was up 23.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.72 earnings per share. On average, analysts anticipate that Molina Healthcare Inc. will post $2.74 EPS for the current year.
MOH has been the subject of a number of analyst reports. Jefferies Group reissued a “buy” rating and set a $63.00 target price (down previously from $66.00) on shares of Molina Healthcare in a research report on Thursday, July 28th. Zacks Investment Research cut shares of Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, October 3rd. Leerink Swann reissued an “outperform” rating and set a $75.00 target price on shares of Molina Healthcare in a research report on Wednesday, June 15th. Goldman Sachs Group Inc. raised shares of Molina Healthcare from a “sell” rating to a “neutral” rating and increased their target price for the company from $51.00 to $58.00 in a research report on Monday, September 19th. Finally, Credit Suisse Group AG reissued a “hold” rating on shares of Molina Healthcare in a research report on Tuesday, June 28th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. Molina Healthcare presently has an average rating of “Hold” and an average price target of $62.80.
In related news, Director Ronna Romney sold 750 shares of Molina Healthcare stock in a transaction that occurred on Thursday, July 28th. The shares were sold at an average price of $55.00, for a total value of $41,250.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Garrey Carruthers sold 1,600 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, September 13th. The stock was sold at an average price of $55.46, for a total transaction of $88,736.00. Following the completion of the transaction, the director now owns 9,508 shares of the company’s stock, valued at approximately $527,313.68. The disclosure for this sale can be found here. 6.89% of the stock is currently owned by corporate insiders.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other. Its Health Plans segment consists of health plans in approximately 10 states and the Commonwealth of Puerto Rico, and its direct delivery business.
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare Inc. (NYSE:MOH).
Receive News & Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.